Genome-Wide Analysis of Codon Usage Patterns of SARS-CoV-2 Virus Reveals Global Heterogeneity of COVID-19

被引:19
|
作者
Khattak, Saadullah [1 ,2 ]
Rauf, Mohd Ahmar [2 ,3 ]
Zaman, Qamar [4 ]
Ali, Yasir [5 ]
Fatima, Shabeen [6 ]
Muhammad, Pir [7 ]
Li, Tao [1 ]
Khan, Hamza Ali [4 ]
Khan, Azhar Abbas [1 ,8 ]
Ngowi, Ebenezeri Erasto [1 ]
Wu, Dong-Dong [1 ,9 ]
Ji, Xin-Ying [1 ,10 ]
机构
[1] Henan Univ, Henan Int Joint Lab Nucl Prot Regulat, Sch Basic Med Sci, Kaifeng 475004, Henan, Peoples R China
[2] Henan Univ, Sch Life Sci, Kaifeng 475004, Henan, Peoples R China
[3] Wayne State Univ, Sch Pharmaceut Sci, Detroit, MI 48202 USA
[4] Hazara Univ, Dept Bioinformat, Mansehra 21120, Pakistan
[5] Quaid I Azam Univ, Natl Ctr Bioinformat, Islamabad 45320, Pakistan
[6] Capital Univ Sci & Technol, Dept Biosci & Bioinformat, Islamabad 44000, Pakistan
[7] Henan Univ, Sch Life Sci, Henan Macquarie Univ Joint Ctr Biomed Innovat, Kaifeng 475004, Henan, Peoples R China
[8] Hazara Univ, Dept Biochem, Mansehra 21110, Pakistan
[9] Henan Univ, Sch Stomatol, Kaifeng 475004, Henan, Peoples R China
[10] Henan Univ, Kaifeng Key Lab Infect & Biol Safety, Sch Basic Med Sci, Kaifeng 475004, Henan, Peoples R China
基金
中国国家自然科学基金;
关键词
Coronavirus; SARS-CoV-2; Codon usage bias; COVID-19; heterogeneity of COVID-19; mutational bias; natural selection; MULTIPLE SEQUENCE ALIGNMENT; NUCLEOTIDE COMPOSITION; MUTATION PRESSURE; MOLECULAR-BIOLOGY; BIAS; CORONAVIRUS; RNA; EVOLUTION; ADAPTATION; VACCINE;
D O I
10.3390/biom11060912
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ongoing outbreak of coronavirus disease COVID-19 is significantly implicated by global heterogeneity in the genome organization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The causative agents of global heterogeneity in the whole genome of SARS-CoV-2 are not well characterized due to the lack of comparative study of a large enough sample size from around the globe to reduce the standard deviation to the acceptable margin of error. To better understand the SARS-CoV-2 genome architecture, we have performed a comprehensive analysis of codon usage bias of sixty (60) strains to get a snapshot of its global heterogeneity. Our study shows a relatively low codon usage bias in the SARS-CoV-2 viral genome globally, with nearly all the over-preferred codons' A.U. ended. We concluded that the SARS-CoV-2 genome is primarily shaped by mutation pressure; however, marginal selection pressure cannot be overlooked. Within the A/U rich virus genomes of SARS-CoV-2, the standard deviation in G.C. (42.91% +/- 5.84%) and the GC3 value (30.14% +/- 6.93%) points towards global heterogeneity of the virus. Several SARS-CoV-2 viral strains were originated from different viral lineages at the exact geographic location also supports this fact. Taking all together, these findings suggest that the general root ancestry of the global genomes are different with different genome's level adaptation to host. This research may provide new insights into the codon patterns, host adaptation, and global heterogeneity of SARS-CoV-2.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Genome-wide association analysis of COVID-19 mortality risk in SARS-CoV-2 genomes identifies mutation in the SARS-CoV-2 spike protein that colocalizes with P.1 of the Brazilian strain
    Hahn, Georg
    Wu, Chloe M.
    Lee, Sanghun
    Lutz, Sharon M.
    Khurana, Surender
    Baden, Lindsey R.
    Haneuse, Sebastien
    Qiao, Dandi
    Hecker, Julian
    DeMeo, Dawn L.
    Tanzi, Rudolph E.
    Choudhary, Manish C.
    Etemad, Behzad
    Mohammadi, Abbas
    Esmaeilzadeh, Elmira
    Cho, Michael H.
    Li, Jonathan Z.
    Randolph, Adrienne G.
    Laird, Nan M.
    Weiss, Scott T.
    Silverman, Edwin K.
    Ribbeck, Katharina
    Lange, Christoph
    GENETIC EPIDEMIOLOGY, 2021, 45 (07) : 685 - 693
  • [22] SARS-CoV-2, the Virus that Causes COVID-19: Cytometry and the New Challenge for Global Health
    Cossarizza, Andrea
    De Biasi, Sara
    Guaraldi, Giovanni
    Girardis, Massimo
    Mussini, Cristina
    CYTOMETRY PART A, 2020, 97 (04) : 340 - 343
  • [23] The continued global battle against SARS-CoV-2 and COVID-19
    Deng, Chu-Xia
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (06): : 1440 - 1442
  • [24] SPONTANEOUS PNEUMOMEDIASTINUM IN PATIENTS WITH SARS-COV-2 VIRUS (COVID-19)
    Ghani, Marium
    Rodriguez-Ortiz, Yariana
    Ahmad, Darakhshan
    Pham, Judy
    Tamsukhin, Phanthira
    Mir, Parvez
    CHEST, 2020, 158 (04) : 1231A - 1232A
  • [25] Ozone: A Potential Oxidant for COVID-19 Virus (SARS-CoV-2)
    Tizaoui, Chedly
    OZONE-SCIENCE & ENGINEERING, 2020, 42 (05) : 378 - 385
  • [26] Vitamin D and SARS-CoV-2 virus/COVID-19 disease
    Lanham-New, Susan A.
    Webb, Ann R.
    Cashman, Kevin D.
    Buttriss, Judy L.
    Fallowfield, Joanne L.
    Masud, Tash
    Hewison, Martin
    Mathers, John C.
    Kiely, Mairead
    Welch, Ailsa A.
    Ward, Kate A.
    Magee, Pamela
    Darling, Andrea L.
    Hill, Tom R.
    Greig, Carolyn
    Smith, Colin P.
    Murphy, Richard
    Leyland, Sarah
    Bouillon, Roger
    Ray, Sumantra
    Kohlmeier, Martin
    BMJ NUTRITION, PREVENTION & HEALTH, 2020, 3 (01) : 106 - 110
  • [27] SARS-CoV-2 (COVID-19): Beginning to Understand a New Virus
    Van Vo, Giau
    Bagyinszky, Eva
    Park, Yoon Soo
    Hulme, John
    An, Seong Soo A.
    CLINICAL, BIOLOGICAL AND MOLECULAR ASPECTS OF COVID-19, 2021, 1321 : 3 - 19
  • [28] Analysis of SARS-CoV-2 vaccine against COVID-19
    Kazuyori, Taisuke
    Sato, Akihito
    Morimoto, Yasuhiro
    Ito, Akihiko
    Kuwano, Kazuyoshi
    RESPIROLOGY, 2023, 28 : 202 - 203
  • [29] Focus on SARS-CoV-2 and COVID-19
    Chen, Sharon C-A.
    Rawlinson, William D.
    PATHOLOGY, 2020, 52 (07) : 743 - 744
  • [30] SARS-CoV-2 and the pandemic of COVID-19
    Adil, Md Tanveer
    Rahman, Rumana
    Whitelaw, Douglas
    Jain, Vigyan
    Al-Taan, Omer
    Rashid, Farhan
    Munasinghe, Aruna
    Jambulingam, Periyathambi
    POSTGRADUATE MEDICAL JOURNAL, 2021, 97 (1144) : 110 - 116